What Is Opzelura Cream and How Does It Work
Lecheng2026-02-12T15:24:06+08:00Opzelura cream treats eczema and vitiligo by blocking JAK enzymes, reducing skin inflammation and itch without steroid side effects.
The Dawn of Regeneration: Pioneering iPSC Therapies Rewrite the Narrative of Incurable Diseases
Lecheng2026-02-24T13:20:53+08:00Discover the historic approval of ReHeart for heart disease and Amchepry for Parkinson’s in Japan. Learn how these first iPS cell products work under conditional time-limited approval and what it means for the future of medicine.
Histotripsy Treatment Risks You Should Know In 2026
Lecheng2026-02-12T15:29:17+08:00Histotripsy treatment offers fewer side effects and quick recovery, but cancer patients should know about rare risks like bleeding, infection, and tumor spread.
BNCT at Lecheng: Precision Radiotherapy and New Frontiers in Cancer Care
Lecheng2026-07-14T13:18:22+08:00Within the rapidly evolving landscape of oncology at the Lecheng International Medical Tourism Pilot Zone, I have witnessed the convergence of global innovation and clinical need. Among the most compelling advances is the arrival of Boron Neutron Capture Therapy (BNCT), a modality that compels us to reconsider the fundamental paradigms of radiation oncology. It moves beyond [...]
Cell And Gene Therapy Technologies Being Implemented In Lecheng, Hainan
Lecheng2026-01-29T13:38:35+08:00Discover the 19 approved cell and gene therapy treatments available at Lecheng, including stem cell and immunotherapies for various conditions. Explore this comprehensive guide.
Halting the Degenerative Cascade: Lecheng’s Novel Biological Therapies for Osteoarthritis
Lecheng2026-01-23T14:37:40+08:00Lecheng offers innovative osteoarthritis treatments including Supintro™ HA gel, Hyalofast cartilage scaffold & autologous SVF therapy for pain relief & joint function restoration.
Reversing the Tide: How Lecheng Fights Diabetes with Stem Cells and Precision Nutrition
Lecheng2026-07-17T15:48:53+08:00Lecheng pioneers a comprehensive approach to Type 2 Diabetes, combining human umbilical cord-derived mesenchymal stem cell (MSC) therapy with Lebentu, China's first specialized medical food. Explore this dual strategy for metabolic restoration.
A Ray of Hope for Vision: Lecheng Debuts Raxone, the First Authorized Treatment for LHON in China
Lecheng2026-01-21T14:06:12+08:00Lecheng introduces Raxone (idebenone), China's first authorized treatment for Leber's Hereditary Optic Neuropathy (LHON), offering hope for this rare mitochondrial disease.
Re-pigmenting Lives: How Lecheng is Introducing Opzelura, a Groundbreaking Topical Therapy for Vitiligo
Lecheng2026-01-21T13:36:35+08:00Lecheng becomes the first in China to offer Opzelura, a breakthrough topical JAK inhibitor for repigmentation in vitiligo. Discover how it works and its advantages over traditional therapies.
